# New Enterprise Associates' Pharma Investments: 15 Startups in Its Portfolio (2026)

> The 15 Pharma startups New Enterprise Associates has backed, by stage: $3.2B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/new-enterprise-associates-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Series B

7

- [CRISPR THERAPEUTICS](https://millionrounds.com/company/crispr-therapeutics)
- [Allakos](https://millionrounds.com/company/allakos)
- [Clementia Pharmaceuticals](https://millionrounds.com/company/clementia-pharmaceuticals)
- [Comanche Biopharma](https://millionrounds.com/company/comanche-biopharma)
- [Cerecor](https://millionrounds.com/company/cerecor)
- [Amplyx Pharmaceuticals](https://millionrounds.com/company/amplyx-pharmaceuticals)
- [*EP* ESP Pharma](https://millionrounds.com/company/esp-pharma)

## Stage not reported

5

- [Resilience](https://millionrounds.com/company/resilience)
- [Aurinia Pharmaceuticals](https://millionrounds.com/company/aurinia-pharmaceuticals)
- [Zosano Pharma](https://millionrounds.com/company/zosano-pharma)
- [Vitae Pharmaceuticals](https://millionrounds.com/company/vitae-pharmaceuticals)
- [NexImmune](https://millionrounds.com/company/neximmune)

## Series C and later

3

- [Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma)
- [ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals)
- [Inversago Pharma](https://millionrounds.com/company/inversago-pharma)

## Segment by segment

### Series B

7 startups · $1.1B raised

- [**CRISPR THERAPEUTICS**](https://millionrounds.com/company/crispr-therapeutics) CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. United States $550M
- [**Allakos**](https://millionrounds.com/company/allakos) Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases. United States $294M
- [**Clementia Pharmaceuticals**](https://millionrounds.com/company/clementia-pharmaceuticals) Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. Canada $93M
- [**Comanche Biopharma**](https://millionrounds.com/company/comanche-biopharma) Comanche Biopharma Corp. United States $75M
- [**Cerecor**](https://millionrounds.com/company/cerecor) Cerecor discovers, develops and commercializes neuroscience drugs. United States $71M
- [**Amplyx Pharmaceuticals**](https://millionrounds.com/company/amplyx-pharmaceuticals) Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immu United States $42M
- [*EP* **ESP Pharma**](https://millionrounds.com/company/esp-pharma) E Shop Pharmacy is a discount worldwide pharmacy fulfillment service. United States $20M

### Stage not reported

5 startups · $1.4B raised

- [**Resilience**](https://millionrounds.com/company/resilience) Resilience is a cyber risk company based in San Francisco, founded in 2016 by experts from military intelligence, insurance, and technology. United States $860M
- [**Aurinia Pharmaceuticals**](https://millionrounds.com/company/aurinia-pharmaceuticals) Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases. Canada $255M
- [**Zosano Pharma**](https://millionrounds.com/company/zosano-pharma) Zosano Pharma (ZSAN) is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics w United States $159M
- [**Vitae Pharmaceuticals**](https://millionrounds.com/company/vitae-pharmaceuticals) Vitae Pharmaceuticals is a clinical-stage biopharmaceutical company building a portfolio of novel, small molecule, best-in-class c United States $79M
- [**NexImmune**](https://millionrounds.com/company/neximmune) NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology. United States $8.9M

### Series C and later

3 startups · $737M raised

- [**Zenas BioPharma**](https://millionrounds.com/company/zenas-biopharma) Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. United States $420M
- [**ORIC Pharmaceuticals**](https://millionrounds.com/company/oric-pharmaceuticals) ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance. United States $248M
- [**Inversago Pharma**](https://millionrounds.com/company/inversago-pharma) Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists Canada $69M

**How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names New Enterprise Associates as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **New Enterprise Associates' AI portfolio** 108 startups · $50B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-ai-portfolio)[Sector portfolio **New Enterprise Associates' Biotech portfolio** 104 startups · $16B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-biotech-portfolio)[Sector portfolio **New Enterprise Associates' Big Data & Analytics portfolio** 39 startups · $2.6B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-big-data-analytics-portfolio)[Sector portfolio **New Enterprise Associates' IT Services portfolio** 38 startups · $4.3B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-it-services-portfolio)[Sector portfolio **New Enterprise Associates' Fintech portfolio** 38 startups · $8.9B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-fintech-portfolio)[Sector portfolio **New Enterprise Associates' Internet portfolio** 32 startups · $4.1B](https://millionrounds.com/portfolio-maps/new-enterprise-associates-internet-portfolio)

## Raising from investors like New Enterprise Associates?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
